SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-24-006893
Filing Date
2024-03-20
Accepted
2024-03-20 18:00:53
Documents
2
Period of Report
2023-09-15

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1590
2 POA exhibit24-1.txt EX-24.1 3393
  Complete submission text file 0001062993-24-006893.txt   6547
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Issuer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O OCUGEN, INC. 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address
Breininger Michael (Reporting) CIK: 0001996457 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36751 | Film No.: 24768835